Hummingbird Nano, Inc.
3-dimensional nanoscale fluid pathway manufacturing technology for micro/nanofluidics structures
- Sector
- Biotech
- Headquarters
- Nicholasville, KY
- Latest Form D
- $450K, Feb 2023
- Total capital
- $3.4M
- Federal grants
- $1M
- 2 awards · 2016–2021
- Rank in peer group#15 of 18
- Private capital raised
- $2.4M
- 3 Form D · last Feb 2023
- 45 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 6 pending · first 2023
- Rank in peer group#5 of 18
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$450K
- Federal grantNSF · Phase I · SBIR Phase I: Feasibility of Dynamic Configurable Liquid Molding$256K
- Private capital raisedForm D · SEC · 2nd filing$925K
- Private capital raisedForm D · SEC · 1st filing$1M
- Federal grantNSF · Phase II · SBIR Phase II: Innovative Platform Technology for Rapid Three Dimensional Fabrication of Capillary Electrophoresis Chips: Phase II Proposal$747K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
27months
from Hummingbird Nano, Inc.’s first federal award to its first private round.
- First federal award · Apr 2016
- NSF · $747K
- First Form D · Jul 2018
- $1M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 18 peers
Line = medianBiotech · Material
- Federal grantsBelow median
- Granted patents#5 · top 28%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Eleanor Grant HawesResearcherExecutive OfficerLinked by $747K in grants as PI
- Billy Grant HarperDirectorNamed in SEC Form D filings
- Candace GilletteExecutive OfficerNamed in SEC Form D filings
- Jon Grant ChaitDirectorNamed in SEC Form D filings
- Kevin Grant KellyDirectorNamed in SEC Form D filings
- LYNDON SCOTT STEPHENSExecutive Officer, DirectorNamed in SEC Form D filings
Show all 8 people
- Raymond Grant StephensDirectorNamed in SEC Form D filings
- Tony Grant OlivitoDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 8- GrantedMicrofluidic Device And Method Of ManufactureUSPTOUS 12,296,509
- PendingHydrodynamic And Gravity Method Of Forming And Shaping Tapered Microfluidic Devices And ProductsUSPTOApplication 18135109
- GrantedMethods For Forming Extruded Shapes With Hydrodynamic Focusing Apparatus And Optionally Smart Core FluidsUSPTOUS 11,801,627
Show all 8 patent records
- Microfluidic Device And Method Of ManufactureMay 13, 2025 · US 12,296,509Granted
- Hydrodynamic And Gravity Method Of Forming And Shaping Tapered Microfluidic Devices And ProductsNov 23, 2023 · Application 18135109Pending
- Methods For Forming Extruded Shapes With Hydrodynamic Focusing Apparatus And Optionally Smart Core FluidsOct 31, 2023 · US 11,801,627Granted
- Hydrodynamic And Gravity Focusing Apparatus And Method Of Forming And Shaping Microfluidic DevicesAug 10, 2023 · Application 17960120Pending
- Microfluidic Device And Method Of ManufactureApplication PCTUS2017051212Pending
- Hydrodynamic And Gravity Method Of Forming And Shaping Tapered Microfluidic DevicesApplication 63331253Pending
- Microfluidic Device And Method Of ManufactureApplication PCTUS2019045961Pending
- Hydrodynamic And Gravity Method Of Forming And Shaping Tapered Microfluidic Devices And ProductsApplication PCTUS2023018739Pending
Related companies, and why
- ORICULA THERAPEUTICS, LLCSimilar federal contract value in Biotech · null in contracts
- Quantum Insights, Inc.Similar federal contract value in Biotech · null in contracts
- TALUS BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts
- Upstream BioSimilar federal contract value in Biotech · null in contracts
- BIOMEDIT LLCSimilar federal contract value in Biotech · null in contracts
- ELGIA THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .